6CM
ARAV

683 Capital Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

683 Capital Management’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,756
Closed -$202K – 184
2019
Q4 		$202K Buy
+14,756
New +$130K 0.02% 102

Other funds holding ARAV

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

683 Capital Management's ARAV Position: Q1 2020 in Review

683 Capital Management sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2020, closing a stake of 14,756 shares — an estimated $202K sold.

683 Capital Management first reported a position in ARAV in Q4 2019 and held it in 1 quarter. The position peaked at $202K in Q4 2019. 35 funds tracked by Wall St. Rank hold ARAV as of Q1 2020.

  • 683 Capital Management reported no remaining Aravive, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • 683 Capital Management sold 14,756 Aravive, Inc. Common Stock shares in Q1 2020, an estimated $202K.
  • 683 Capital Management first reported a position in Aravive, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • 683 Capital Management's Aravive, Inc. Common Stock position peaked at $202K in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2020.

Based on 683 Capital Management's 13F filing for Q1 2020, filed 15 May 2020.